Medical technology innovator Oncotech Nordic AB has been awarded CE marking for the mobile health screening app, Ophtascan™, which is currently being trialled by doctors and patients in Central Africa, where there is huge demand for cancer screening and diagnosis. The new screening app is being used by Sigma Africa clinicians in the Central African Republic, Democratic Republic of Congo, Liberia and Tanzania. The Ophtascan™ mobile phone app works by a clinician taking a high resolution photographic image of the patient’s eyes, which...